Skip to main content

We make finding a doctor in the UAE free, transparent, and easy.

What should you know about capivasertib tnbc?

How the structures involved in Triple-Negative Breast Cancer differ from normal
Illustration: How the structures involved in Triple-Negative Breast Cancer differ from normal

Short answer

Capivasertib is an oral targeted medicine that blocks AKT signalling, but its suitability for triple-negative breast cancer requires specialist assessment.

This answers one question. It is not a diagnosis and does not replace an assessment by a licensed doctor.

At a glance

Medicine type
Capivasertib is an oral targeted medicine that inhibits AKT proteins.
Eligibility
TNBC status alone does not establish that capivasertib is suitable.
Monitoring
The care plan may include blood sugar checks, other blood tests, and active review of bowel and skin symptoms.

Direct answer

TNBC lacks the usual treatment targets defined by oestrogen receptors, progesterone receptors, and HER2. That description does not show whether an individual tumour depends on the AKT pathway or whether capivasertib belongs in a person's care. The oncology team must interpret the cancer's stage, prior treatment, tumour results, health conditions, and available treatment options together.

How AKT targeting fits into treatment

AKT proteins sit within a cell-signalling pathway that can support cancer-cell growth and survival. Capivasertib inhibits AKT activity. Tumour testing may look for changes in genes connected with this pathway, but a result must be interpreted in the context of the exact treatment setting rather than treated as a stand-alone prescription.

Targeted therapy can be paired with another anticancer medicine because blocking one signal may not control all cancer cells. For TNBC, the broader plan may include chemotherapy, immunotherapy, a PARP inhibitor for an appropriate inherited or tumour feature, surgery, or radiotherapy. The sequence depends on whether disease is localised or has spread and on treatment already received.

What to discuss before and during treatment

Ask why capivasertib is being considered, what it would be combined with, and which tumour or blood-test finding supports that choice. Give the team a complete list of prescribed medicines, over-the-counter products, and supplements so they can check interactions. Mention diabetes or high blood sugar, bowel problems, skin conditions, and any chance of pregnancy.

Take the medicine only on the schedule supplied by the oncology team. Do not double a dose after vomiting or a missed tablet unless the written instructions specifically direct it. Attend requested blood tests and report diarrhoea, rash, mouth soreness, nausea, reduced appetite, or fatigue early; timely supportive care may prevent symptoms from becoming harder to manage.

When side effects need urgent advice

Contact the oncology service urgently for severe or persistent diarrhoea, inability to keep fluids down, very little urine, marked weakness, confusion, or symptoms of high blood sugar such as unusual thirst and frequent urination. A widespread blistering or peeling rash, sores affecting the eyes or mouth, facial swelling, breathing difficulty, fainting, or fever with feeling acutely unwell needs immediate medical assessment. Follow the treatment team's emergency instructions.

Questions for your oncology team

Request the precise goal of treatment and how the team will tell whether it is helping. Ask which side effects should trigger a same-day call, how blood sugar and other blood results will be monitored, and what to do about a missed dose. It is also useful to clarify alternative options, contraception guidance, and whether genetic counselling or further tumour testing would change the wider plan.

Questions people ask

Is capivasertib a type of chemotherapy?

No. It is a targeted medicine that inhibits AKT signalling. It may be considered alongside another treatment rather than serving as a direct substitute for every chemotherapy option.

Does having TNBC mean capivasertib will be offered?

No. Suitability depends on the treatment setting, tumour information, prior therapy, other medical conditions, and the options judged appropriate by the oncology team.

Why does blood sugar matter during capivasertib treatment?

AKT inhibition can disturb glucose control. The team may check blood sugar and needs to know promptly about increased thirst, frequent urination, confusion, or unusual weakness.

Related

Related reading

Keep reading

More on this

Cancer care in the UAE

Hospitals & Medical Centers in Abu Dhabi

Most UAE cancer care is delivered inside hospital services rather than by standalone oncology clinics, so these are licensed hospitals & medical centers listed in Abu Dhabi. Confirm the specific cancer service exists before you travel, and know that asking for a second opinion is routine.

City
  • Ahalia Hospital Musaffah Building - Musaffah - Musaffah Industrial - Abu Dhabi - United Arab Emirates

    Accepts: Daman, Thiqa, AXA, Cigna +26 more

  • Al Ruwais Industrial City - Abu Dhabi - United Arab Emirates

    Accepts: Daman, Thiqa, AXA, Cigna +30 more

  • Abu Dhabi, Abu Dhabi

    Accepts: Daman, Thiqa, AXA, Cigna +30 more

Second opinions are routine in cancer care and asking for one does not affect your treatment. How to arrange a second opinion in the UAE.

Ordered by verification status and how complete each clinic's public record is, then alphabetically. This is a directory listing, not a ranking — Zavis does not rate or recommend providers.

A factual listing drawn from the DHA, DOH and MOHAP licence registers. It is not a referral, an endorsement, or advice that any of these providers is right for you.

Medical disclaimer. This page is general health information, not medical advice, and it cannot diagnose you. Always consult a licensed healthcare provider about your own symptoms and treatment. In an emergency in the UAE, call 998 for an ambulance.